性传播感染的诊断与治疗:一项综述
该综述汇总了淋病、衣原体感染、梅毒、生殖支原体、滴虫病及生殖器疱疹的流行病学、诊断与治疗进展。2015至2019年美国淋病、衣原体和梅毒发病率上升,而HSV-1和HSV-2发病率下降;核酸扩增试验对多种性传播感染具有高敏感性和特异性。头孢曲松、多西环素、青霉素、莫西沙星和硝基咪唑类分别为上述感染的有效治疗,但抗菌药物耐药限制了淋病和生殖支原体的口服治疗选择,生殖器疱疹无治愈方法。
要点
- 2018年美国约五分之一成人患有性传播感染。
- 2015至2019年美国淋病、衣原体和梅毒发病率上升。
- 头孢曲松、多西环素、青霉素、莫西沙星和硝基咪唑类分别为淋病、衣原体、梅毒、生殖支原体和滴虫病的有效治疗。
核心结论
- 2018年美国约五分之一成人患有性传播感染。
- 2015至2019年美国淋病、衣原体和梅毒发病率上升,而HSV-1和HSV-2发病率下降。
- 头孢曲松、多西环素、青霉素、莫西沙星和硝基咪唑类分别为淋病、衣原体感染、梅毒、生殖支原体和滴虫病的有效治疗。
- 抗菌药物耐药限制了淋病和生殖支原体的口服治疗选择,生殖器疱疹无治愈方法。
研究设计与样本
- 综述,更新淋病、衣原体感染、梅毒、生殖支原体、滴虫病及生殖器疱疹的流行病学、诊断和治疗。
主要发现
- 2018年美国约五分之一成人患有性传播感染。
- 2015至2019年美国淋病、衣原体和梅毒发病率上升;1999至2016年HSV-1和HSV-2发病率下降。
- 性传播感染高发人群包括25岁以下人群、男男性行为者和跨性别女性等性少数与性别少数群体、黑人和拉丁裔等种族与族裔少数群体。
- 约70%的HSV和滴虫病感染以及53%至100%的生殖器外淋病和衣原体感染为无症状或症状轻微。
- 性传播感染与HIV获得和传播相关,并且是女性输卵管因素不孕的主要原因。
关键数值与推荐
- 核酸扩增试验诊断淋病、衣原体、生殖支原体、滴虫病及有症状的HSV-1和HSV-2的敏感性为86.1%-100%,特异性为97.1%-100%。
- 血清学仍是诊断梅毒的推荐方法,通常采用序贯检测以检出密螺旋体抗体和非密螺旋体(抗磷脂)抗体。
临床怎么用
- 头孢曲松、多西环素、青霉素、莫西沙星和硝基咪唑类(如甲硝唑)分别为淋病、衣原体感染、梅毒、生殖支原体和滴虫病的有效治疗。
- 抗菌药物耐药限制了淋病和生殖支原体的口服治疗选择,生殖器疱疹无治愈方法。
- 有效的性传播感染预防干预包括筛查、性伴侣接触者追踪和推广有效的屏障避孕。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Approximately 1 in 5 adults in the US had a sexually transmitted infection (STI) in 2018. This review provides an update on the epidemiology, diagnosis, and treatment of gonorrhea, chlamydia, syphilis, Mycoplasma genitalium, trichomoniasis, and genital herpes. OBSERVATIONS: From 2015 to 2019, the rates of gonorrhea, chlamydia, and syphilis increased in the US; from 1999 to 2016, while the rates of herpes simplex virus type 1 (HSV-1) and HSV-2 declined. Populations with higher rates of STIs include people younger than 25 years, sexual and gender minorities such as men and transgender women who have sex with men, and racial and ethnic minorities such as Black and Latinx people. Approximately 70% of infections with HSV and trichomoniasis and 53% to 100% of extragenital gonorrhea and chlamydia infections are asymptomatic or associated with few symptoms. STIs are associated with HIV acquisition and transmission and are the leading cause of tubal factor infertility in women. Nucleic acid amplification tests have high sensitivities (86.1%-100%) and specificities (97.1%-100%) for the diagnosis of gonorrhea, chlamydia, M genitalium, trichomoniasis, and symptomatic HSV-1 and HSV-2. Serology remains the recommended method to diagnose syphilis, typically using sequential testing to detect treponemal and nontreponemal (antiphospholipid) antibodies. Ceftriaxone, doxycycline, penicillin, moxifloxacin, and the nitroimidazoles, such as metronidazole, are effective treatments for gonorrhea, chlamydia, syphilis, M genitalium, and trichomoniasis, respectively, but antimicrobial resistance limits oral treatment options for gonorrhea and M genitalium. No cure is available for genital herpes. Effective STI prevention interventions include screening, contact tracing of sexual partners, and promoting effective barrier contraception. CONCLUSIONS AND RELEVANCE: Approximately 1 in 5 adults in the US had an STI in 2018. Rates of gonorrhea, chlamydia, and syphilis in the US have increased, while rates of HSV-1 and HSV-2 have declined. Ceftriaxone, doxycycline, penicillin, moxifloxacin, and the nitroimidazoles are effective treatments for gonorrhea, chlamydia, syphilis, Mycoplasma genitalium, and trichomoniasis, respectively, but antimicrobial resistance limits oral therapies for gonorrhea and Mycoplasma genitalium, and no cure is available for genital herpes.
引用
- Tuddenham S, Hamill MM, Ghanem KG, et al. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. JAMA. 2022. PMID: 35015033. doi:10.1001/jama.2021.23487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。